Public Reporting Data

ACO Name and Location

North Collaborative Care
3300 Oakdale Ave. N.
Robbinsdale, MN 55422

Primary ACO Contact

Primary Contact Name Jason Rusinak
Primary Contact Phone Number 763-581-2414
Primary Contact Email Address jason.rusinak@northmemorial.com

Organizational Information

ACO Participants:

ACO Participant

ACO Participant in Joint Venture (Enter Y or N)
Maple Grove Hospital Corporation N
North Memorial Health Y
Northwest Family Physicians Y

ACO Governing Body:

Member Member’s Voting Power
– Expressed as a percentage or number		 Membership Type ACO Participant Legal Business Name/DBA, if Applicable

Last Name

First Name

Title/Position
Shah, MD Meetul Voting Member 1 Vote ACO Participant Representative Blaze Health
Bache-Wiig, MD Ben Voting Member 1 Vote ACO Participant Representative Lifespark
Reichel, MD Scott Voting Member 1 Vote ACO Participant Representative Northwest Family Physicians
Ogland, MD Carolyn Chair of the Board, Voting Member 1 Vote ACO Participant Representative North Memorial Health
Fromm Dan Voting Member 1 Vote ACO Participant Representative North Memorial Health
Vespa, MD Jeff Voting Member 1 Vote ACO Participant Representative North Memorial Health
Ryder Jon Voting Member 1 Vote Medicare Beneficiary Representative  

Key ACO Clinical and Administrative Leadership:

Dr. Carolyn Ogland ACO Executive
Dr. Carolyn Ogland Medical Director
Dawn Backlund Compliance Officer
Dr. Kari Fabian Quality Assurance/Improvement Director

Associated Committees and Committee Leadership:

Committee Name Committee Leader Name and Position
NCC Quality Committee Dr. Kari Fabian, Quality Committee Chair
NCC Finance Committee Dr. Scott Colson, Finance Committee Chair
NCC Board of Directors Dr. Carolyn Ogland, Board Chair
NCC Compliance Committee Dawn Backlund, Compliance Committee Chair

Types of ACO participants, or combinations of participants, that formed the ACO:

  • Hospital employing ACO professionals
  • Networks of individual practices of ACO professionals

Shared Savings and Losses

Amount of Shared Savings/(Losses)

  • Third Agreement Period: Enhanced Track
    • Performance Year 2021: $0
    • Performance Year 2020: $0
  • Second Agreement Period
    • Performance Year 2019: $186,611
      • Performance Year 2019 A: $0
    • Performance Year 2018 ($1,283,929)
    • Performance Year 2017: ($1,523,336)
  • First Agreement Period
    • Performance Year 2016: $2,135,157
    • Performance Year 2015: $2,709,506
    • Performance Year 2014: $2,077,491

Shared Savings Distribution

  • Third Agreement Period
    • Performance Year 2021
      • Proportion invested in infrastructure: 12%
      • Proportion invested in redesigned care processes/resources: 0%
      • Proportion of distribution to ACO participants: 88%
    • Performance Year 2020
      • Proportion invested in infrastructure: 12%
      • Proportion invested in redesigned care processes/resources: 0%
      • Proportion of distribution to ACO participants: 88%
  • Second Agreement Period
    • Performance Year 2019
      • Proportion invested infrastructure: 12%
      • Proportion invested in redesigned care processes/resources: 0%
      • Proportion of distribution to ACO participants: 88%
    • Performance Year 2018
      • Proportion invested in infrastructure: 12%
      • Proportion invested in redesigned care processes/resources: 0%
      • Proportion of distribution to ACO participants: 88%
    • Performance Year 2017
      • Proportion invested in infrastructure: 10%
      • Proportion invested in redesigned care processes/resources: 0%
      • Proportion of distribution to ACO participants: 90%
  • First Agreement Period
    • Performance Year 2016
      • Proportion invested in infrastructure: 10%
      • Proportion invested in redesigned care processes/resources: 0%
      • Proportion of distribution to ACO participants: 90%
    •  Performance Year 2015
      • Proportion invested in infrastructure: 10%
      • Proportion invested in redesigned care processes/resources: 0%
      • Proportion of distribution to ACO participants: 90%
    • Performance Year 2014
      • Proportion invested in infrastructure: 10%
      • Proportion invested in redesigned care processes/resources: 0%
      • Proportion of distribution to ACO participants: 90%

Quality Performance Results

2021 Quality Performance Results

Measure # Measure Name Rate ACO Mean
001 Diabetes: Hemoglobin A1c (HbaA1C) Poor Control 13.31 12.46
134 Preventative Care and Screening: Screening for Clinical Depression and Follow-up Plan 77.10 74.38
236 Controlling High Blood Pressure 81.58 74.87
318 Falls: Screening for Future Fall Risk 78.05 87.03
110 Preventative Care and Screening: Influenza Immunization 83.06 80.52
226 Preventative Care and Screening: Tobacco Use: Screening and Cessation Intervention 72.41 80.97
113 Colorectal Cancer Screening 72.23 73.63
112 Breast Cancer Screening 69.89 75.11
438 Statin Therapy for the Prevention and Treatment of Cardiovascular Disease 80.16 84.24
370 Depression Remission at 12 Months 13.64 15.50
321 CAHPS for MIPS N/A N/A
479 Hospital-Wide, 30-Day, All-Cause Unplanned Readmission (HWR) Rate for MIPS Groups 0.1404 0.1540
MCC1 All-Cause Unplanned Admissions for Patients with Multiple Chronic Conditions for ACOs (MCC) 34.01 33.99

Note: In the Quality Performance Results file(s) above, search for “North Collaborative Care” to view the quality performance results. This ACO can also be found by using the ACO ID A45396 in the public use files on data.cms.gov.

Payment Rule Waivers

Our ACO uses the SNF 3-Day Rule Waiver, pursuant to 42 CFR 425.612. “ACOs not approved for a SNF 3-Day Rule Waiver do not need to include this section of the public reporting template on their public reporting webpage.”